| Hepatic stem-like phenotype and interplay of Wnt/β-catenin and Myc signaling in aggressive childhood liver cancer S Cairo, C Armengol, A De Reyniès, Y Wei, E Thomas, CA Renard, ... Cancer cell 14 (6), 471-484, 2008 | 521 | 2008 |
| Tbx3 is a downstream target of the Wnt/β-catenin pathway and a critical mediator of β-catenin survival functions in liver cancer CA Renard, C Labalette, C Armengol, D Cougot, Y Wei, S Cairo, P Pineau, ... Cancer research 67 (3), 901-910, 2007 | 202 | 2007 |
| Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model C Armengol, S Cairo, M Fabre, MA Buendia The international journal of biochemistry & cell biology 43 (2), 265-270, 2011 | 142 | 2011 |
| CD5L promotes M2 macrophage polarization through autophagy-mediated upregulation of ID3 L Sanjurjo, G Aran, É Téllez, N Amézaga, C Armengol, D López, C Prats, ... Frontiers in immunology 9, 480, 2018 | 98 | 2018 |
| The human CD5L/AIM-CD36 axis: a novel autophagy inducer in macrophages that modulates inflammatory responses L Sanjurjo, N Amézaga, G Aran, M Naranjo-Gómez, L Arias, C Armengol, ... Autophagy 11 (3), 487-502, 2015 | 96 | 2015 |
| Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications J Carrillo-Reixach, L Torrens, M Simon-Coma, L Royo, M Domingo-Sàbat, ... Journal of hepatology 73 (2), 328-341, 2020 | 89 | 2020 |
| Molecular bases of the poor response of liver cancer to chemotherapy JJG Marin, O Briz, E Herraez, E Lozano, M Asensio, S Di Giacomo, ... Clinics and Research in Hepatology and Gastroenterology 42 (3), 182-192, 2018 | 77 | 2018 |
| Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management D Nicolle, M Fabre, M Simon‐Coma, A Gorse, R Kappler, L Nonell, ... Hepatology 64 (4), 1121-1135, 2016 | 70 | 2016 |
| Ductular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis B Aguilar‐Bravo, D Rodrigo‐Torres, S Ariño, M Coll, E Pose, D Blaya, ... Hepatology 69 (5), 2180-2195, 2019 | 66 | 2019 |
| Hepatocellular carcinoma: present and future C Armengol, MR Sarrias, M Sala Medicina Clínica (English Edition) 150 (10), 390-397, 2018 | 59 | 2018 |
| CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78) G Aran, L Sanjurjo, C Barcena, M Simon‐Coma, É Téllez, ... The FASEB Journal 32 (7), 3878-3891, 2018 | 54 | 2018 |
| Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake N Amézaga, L Sanjurjo, J Julve, G Aran, B Pérez-Cabezas, ... Journal of leukocyte biology 95 (3), 509-520, 2014 | 53 | 2014 |
| p27Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma C Armengol, L Boix, O Bachs, M Solé, J Fuster, M Sala, JM Llovet, ... Journal of hepatology 38 (5), 591-597, 2003 | 53 | 2003 |
| The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation C Labalette, Y Nouët, J Sobczak-Thepot, C Armengol, F Levillayer, ... Journal of biological chemistry 283 (22), 15201-15208, 2008 | 52 | 2008 |
| Activation of Wnt and Myc signaling in hepatoblastoma S Cairo, C Armengol, MA Buendia Frontiers in Bioscience-Elite 4 (1), 480-486, 2012 | 50 | 2012 |
| Role of scavenger receptors in the pathophysiology of chronic liver diseases C Armengol, R Bartoli, L Sanjurjo, I Serra, N Amezaga, M Sala, ... Critical Reviews™ in Immunology 33 (1), 2013 | 47 | 2013 |
| CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content C Bárcena, G Aran, L Perea, L Sanjurjo, É Téllez, A Oncins, H Masnou, ... EBioMedicine 43, 513-524, 2019 | 35 | 2019 |
| HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis BP Morales, R Planas, R Bartoli, RM Morillas, M Sala, I Casas, ... Digestive and Liver Disease 50 (1), 76-83, 2018 | 35 | 2018 |
| Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line C Armengol, G Tarafa, L Boix, M Solé, R Queralt, D Costa, O Bachs, ... Clinical cancer research 10 (6), 2150-2157, 2004 | 33 | 2004 |
| A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients S Cairo, C Armengol, R Maibach, B Häberle, K Becker, J Carrillo-Reixach, ... European Journal of Cancer 141, 30-39, 2020 | 19 | 2020 |
